Pages that link to "Q37240441"

The following pages link to Expression of connective tissue growth factor in tumor tissues is an independent predictor of poor prognosis in patients with gastric cancer (Q37240441):

Displaying 29 items.

• Connective tissue growth factor associated with oncogenic activities and drug resistance in glioblastoma multiforme (Q34158700) (← links)
• Structural ECM components in the premetastatic and metastatic niche (Q34521147) (← links)
• Downregulation of connective tissue growth factor inhibits the growth and invasion of gastric cancer cells and attenuates peritoneal dissemination (Q35339610) (← links)
• Estrogenic GPR30 signalling induces proliferation and migration of breast cancer cells through CTGF (Q37133153) (← links)
• Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers. (Q37162642) (← links)
• Differential expression of CCN family members CYR611, CTGF and NOV in gastric cancer and their association with disease progression (Q37321195) (← links)
• Forkhead Transcription Factor Foxq1 Promotes Epithelial–Mesenchymal Transition and Breast Cancer Metastasis (Q37529876) (← links)
• Less Smad2 is good for you! A scientific update on coffee's liver benefits (Q37554158) (← links)
• Cyr61/CTGF/Nov family proteins in gastric carcinogenesis (Q37596182) (← links)
• CTGF is a therapeutic target for metastatic melanoma. (Q37662627) (← links)
• Metastasis-suppressor genes in clinical practice: lost in translation? (Q37869335) (← links)
• Deregulated expression of connective tissue growth factor (CTGF/CCN2) is linked to poor outcome in human cancer (Q38212057) (← links)
• The RNA-binding protein Musashi1 affects medulloblastoma growth via a network of cancer-related genes and is an indicator of poor prognosis (Q38321654) (← links)
• A potential role for CCN2/CTGF in aggressive colorectal cancer (Q38950681) (← links)
• Inhibition of connective tissue growth factor (CTGF/CCN2) in gallbladder cancer cells leads to decreased growth in vitro. (Q39164659) (← links)
• EphB4 is overexpressed in papillary thyroid carcinoma and promotes the migration of papillary thyroid cancer cells (Q39359780) (← links)
• GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells. (Q39432208) (← links)
• Clinicopathological significance of SLP-2 overexpression in human gallbladder cancer (Q47851880) (← links)
• miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis (Q48171440) (← links)
• Oral application of 1,7-dimethylxanthine (paraxanthine) attenuates the formation of experimental cholestatic liver fibrosis (Q50523966) (← links)
• Increased levels of SLP-2 correlate with poor prognosis in gastric cancer. (Q54273631) (← links)
• CTGF is overexpressed in papillary thyroid carcinoma and promotes the growth of papillary thyroid cancer cells. (Q54377230) (← links)
• miR-221 stimulates breast cancer cells and cancer-associated fibroblasts (CAFs) through selective interference with the A20/c-Rel/CTGF signaling. (Q55340090) (← links)
• MiR-218 regulates epithelial-mesenchymal transition and angiogenesis in colorectal cancer via targeting CTGF. (Q55453435) (← links)
• Significance of serum connective tissue growth factor in patients with hepatocellular carcinoma and relationship with angiogenesis (Q84329978) (← links)
• About coffee, cappuccino and connective tissue growth factor—Or how to protect your liver!? (Q84588120) (← links)
• Expression and clinical significance of connective tissue growth factor in advanced head and neck squamous cell cancer (Q87611014) (← links)
• The Extracellular Matrix: An Accomplice in Gastric Cancer Development and Progression (Q89660060) (← links)
• Down-regulation of interferon regulatory factor 2 binding protein 2 suppresses gastric cancer progression by negatively regulating connective tissue growth factor (Q90323427) (← links)